829 related articles for article (PubMed ID: 30667296)
41. [Radioiodine versus surgery in the treatment of Graves' hyperthyroidism].
Jukić T; Stanicić J; Petric V; Kusić Z
Lijec Vjesn; 2010; 132(11-12):355-60. PubMed ID: 21294325
[TBL] [Abstract][Full Text] [Related]
42. Radioactive iodine therapy for pediatric Graves' disease: a single-center experience over a 10-year period.
Kaplowitz PB; Jiang J; Vaidyanathan P
J Pediatr Endocrinol Metab; 2020 Mar; 33(3):383-389. PubMed ID: 31603857
[TBL] [Abstract][Full Text] [Related]
43. Predictors of Prolonged Euthyroidism After Radioactive Iodine Treatment for Graves' Disease: A Pilot Study.
Lu JY; Chen KH; Shih SR; Wen FY; Wu WC; Chen TC; Hu FC
Endocr Pract; 2023 Feb; 29(2):89-96. PubMed ID: 36396015
[TBL] [Abstract][Full Text] [Related]
44. Radioiodine treatment in pediatric Graves' disease and thyroid carcinoma.
Yuan L; Yang J
J Pediatr Endocrinol Metab; 2011; 24(11-12):877-83. PubMed ID: 22308835
[TBL] [Abstract][Full Text] [Related]
45. Thyroid hormone state and quality of life at long-term follow-up after randomized treatment of Graves' disease.
Abraham-Nordling M; Wallin G; Lundell G; Törring O
Eur J Endocrinol; 2007 Feb; 156(2):173-9. PubMed ID: 17287406
[TBL] [Abstract][Full Text] [Related]
46. [The effect of propylthiouracil on the efficacy of radioiodine (I-131) therapy in graves hyperthyroidism].
de Souza MV; Buescu A; Vaisman M; de Souza HF; Luiz RR
Arq Bras Endocrinol Metabol; 2006 Dec; 50(6):1088-95. PubMed ID: 17221116
[TBL] [Abstract][Full Text] [Related]
47. Treatment with lithium prevents serum thyroid hormone increase after thionamide withdrawal and radioiodine therapy in patients with Graves' disease.
Bogazzi F; Bartalena L; Campomori A; Brogioni S; Traino C; De Martino F; Rossi G; Lippi F; Pinchera A; Martino E
J Clin Endocrinol Metab; 2002 Oct; 87(10):4490-5. PubMed ID: 12364424
[TBL] [Abstract][Full Text] [Related]
48. Graves' disease in childhood.
Kraiem Z; Newfield RS
J Pediatr Endocrinol Metab; 2001 Mar; 14(3):229-43. PubMed ID: 11308041
[TBL] [Abstract][Full Text] [Related]
49. Should radioiodine be the first-line treatment for paediatric Graves' disease?
West JD; Cheetham TD; Dane C; Natarajan A
J Pediatr Endocrinol Metab; 2015 Jul; 28(7-8):797-804. PubMed ID: 25719296
[TBL] [Abstract][Full Text] [Related]
50. Graves' hyperthyroidism: treatment with antithyroid drugs, surgery, or radioiodine--a prospective, randomized study. Thyroid Study Group.
Törring O; Tallstedt L; Wallin G; Lundell G; Ljunggren JG; Taube A; Sääf M; Hamberger B
J Clin Endocrinol Metab; 1996 Aug; 81(8):2986-93. PubMed ID: 8768863
[TBL] [Abstract][Full Text] [Related]
51. Hyperthyroidism. Current treatment guidelines.
Gittoes NJ; Franklyn JA
Drugs; 1998 Apr; 55(4):543-53. PubMed ID: 9561343
[TBL] [Abstract][Full Text] [Related]
52. Changes in graves' ophthalmopathy after radioiodine and anti-thyroid drug treatment of Graves' disease from 2 prospective, randomized, open-label, blinded end point studies.
Chen DY; Schneider PF; Zhang XS; Luo XY; He ZM; Chen TH
Exp Clin Endocrinol Diabetes; 2014 Jan; 122(1):1-6. PubMed ID: 24203649
[TBL] [Abstract][Full Text] [Related]
53. The adjunctive use of carbimazole during radioactive iodine treatment reduces the cure rate of Graves' disease.
Docrat F; Mokoena T; Karusseit VOL; Ankrah AO
S Afr Med J; 2021 Feb; 111(2):176-179. PubMed ID: 33944730
[TBL] [Abstract][Full Text] [Related]
54. Long-term outcome of hyperthyroidism diagnosed in childhood and adolescence: a single-centre experience.
Gill DS; Greening JE; Howlett TA; Levy MJ; Shenoy SD
J Pediatr Endocrinol Metab; 2019 Feb; 32(2):151-157. PubMed ID: 30685744
[TBL] [Abstract][Full Text] [Related]
55. Treatment of Graves' disease in children: The Portuguese experience.
Marques O; Antunes A; Oliveira MJ
Endocrinol Diabetes Nutr (Engl Ed); 2018 Mar; 65(3):143-149. PubMed ID: 29325833
[TBL] [Abstract][Full Text] [Related]
56. Long-term thionamide antithyroid treatment of Graves' disease.
Azizi F; Abdi H; Amouzegar A; Habibi Moeini AS
Best Pract Res Clin Endocrinol Metab; 2023 Mar; 37(2):101631. PubMed ID: 35440398
[TBL] [Abstract][Full Text] [Related]
57. The thyroid-related quality of life measure ThyPRO has good responsiveness and ability to detect relevant treatment effects.
Watt T; Cramon P; Hegedüs L; Bjorner JB; Bonnema SJ; Rasmussen ÅK; Feldt-Rasmussen U; Groenvold M
J Clin Endocrinol Metab; 2014 Oct; 99(10):3708-17. PubMed ID: 25004246
[TBL] [Abstract][Full Text] [Related]
58. Radioiodine therapy in hyperthyroidism: inverse correlation of pretherapeutic iodine uptake level and post-therapeutic outcome.
Walter MA; Christ-Crain M; Eckard B; Schindler C; Nitzsche EU; Müller-Brand J; Müller B
Eur J Clin Invest; 2004 May; 34(5):365-70. PubMed ID: 15147334
[TBL] [Abstract][Full Text] [Related]
59. Radioiodine treatment of recurrent hyperthyroidism in patients previously treated for Graves' disease by subtotal thyroidectomy.
Vestergaard H; Laurberg P
J Intern Med; 1992 Jan; 231(1):13-7. PubMed ID: 1732393
[TBL] [Abstract][Full Text] [Related]
60. [Radioiodine therapy of Graves' disease--a dosimetric comparison of various therapy regimens of antithyroid agents].
Urbannek V; Voth E; Moka D; Schicha H
Nuklearmedizin; 2001 Aug; 40(4):111-5. PubMed ID: 11556200
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
